Since glucose dynamics, as observed after insulin-induced hypoglycemia, seem to trigger copeptin secretion, we hypothesized that the difference in glucose dynamics might explain the differences in copeptin release between stimulating tests (arginine and glucagon) and the non-stimulating test (macimorelin). The gene discussed is AVP; the disease is Hypoglycemia.